Evidence map›Paper›PMID 42839941›Full record

ArticleFrontiers in oncology2026

An optimized EfficientNetB7 deep learning model for lung cancer tissue pathology image recognition.

Xiongwen He, Lili Fu, Baicheng Xu, Jingru Luo, Junnv Xu, Shu Lin, Mingfa Wang, Wenjun Tang

Abstract read
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiongwen He *Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Lili Fu *Department of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Baicheng XuDepartment of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Jingru LuoDepartment of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Junnv XuDepartment of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Shu LinDepartment of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Mingfa WangDepartment of Pathology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
Wenjun TangDepartment of Medical Oncology, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lung cancer is the leading cause of cancer deaths worldwide. This study constructed and optimized a deep learning model to recognize lung cancer pathological images for intelligent classification. Methods: The LC25000 dataset was adopted for model training, and the LungHist700 dataset served as independent validation, with validation F1 score as the primary evaluation metric. Nine classic convolutional neural networks (DenseNet201, EfficientNetB7, EfficientNetV2S, InceptionResNetV2, MobileNetV3Large, NASNetLarge, ResNet50V2, VGG19, and Xception) were first benchmarked. Afterwards, three ensemble strategies including Equal-Weighted Averaging, Performance-Weighted Averaging and XGBoost were tested. Meanwhile, hyperparameter tuning was implemented on the optimal single model. Result: All nine baseline models obtained good performance on training and internal test datasets. Among individual models, EfficientNetB7 performed best with an F1 score of 0.891 and AUC of 0.749. Ensemble methods only reached a maximum F1 of 0.889, showing no obvious advantage over the best single model. By contrast, the hyperparameter-optimized EfficientNetB7 achieved remarkable generalization improvement, with accuracy 0.873, precision 0.864, recall 0.999, F1 score0.926 and AUC 0.871. Conclusion: The optimized model effectively recognizes lung cancer pathological images and supplies technical support for intelligent diagnosis. Multi-center large-sample clinical validation is required for future clinical transformation.

Indexed as

convolutional neural networksdeep learninglung cancerpathological imagesrecognition

Identifiers

PMID42839941
PMCPMC13638370

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.